RightFit Trial Directory

Parkinson's Disease clinical trials in Lexington, KY

11 recruiting parkinson's disease studies with a site in Lexington, KY.

All trials in Lexington, KY · All Parkinson's Disease trials

RecruitingPhase 2NCT07432958

A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations

Sponsor: Appello Pharmaceuticals, Inc.

Lexington, KY · +29 more sites

RecruitingPhase 2NCT06680830

A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease

Sponsor: Neuron23 Inc.

Lexington, KY · +44 more sites

RecruitingPhase 2NCT06780085

A Study of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01)

Sponsor: Merck Sharp & Dohme LLC

Lexington, KY · +2 more sites

RecruitingPhase not listedNCT04994015

Parkinson's Foundation PD GENEration Genetic Registry

Sponsor: Parkinson's Foundation

Lexington, KY · +62 more sites

RecruitingPhase 1NCT06683365

Autologous suraL nervE Grafting to the Substantia nigrA in Patients With Synuclienopathies

Sponsor: Craig van Horne, MD, PhD

Lexington, KY

RecruitingPhase 1NCT06683378

A Study to Evaluate Feasibility, Safety, and Clinical Responses of Implanting Autologous Peripheral Nerve Tissue Into the Brain for Non-motor or Motor Symptoms in Patients With Parkinson's Disease Undergoing DBS Surgery

Sponsor: Craig van Horne, MD, PhD

Lexington, KY

RecruitingPhase 1 / Phase 2NCT04165070

KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)

Sponsor: Merck Sharp & Dohme LLC

Lexington, KY · +17 more sites

RecruitingPhase not listedNCT04165798

KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)

Sponsor: Merck Sharp & Dohme LLC

Lexington, KY · +17 more sites

RecruitingPhase 4NCT04373317

Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis

Sponsor: VA Office of Research and Development

Lexington, KY · +23 more sites

RecruitingPhase 1NCT05142189

Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer

Sponsor: BioNTech SE

Lexington, KY · Louisville, KY · +4 more sites

RecruitingPhase 1 / Phase 2NCT06753331

A Multicenter Study to Evaluate Safety, Tolerability, and Clinical Responses of DSP-1083 Into Subjects With Parkinson's Disease

Sponsor: Sumitomo Pharma America, Inc.

Lexington, KY · +1 more sites

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.